NCT06036576View on ClinicalTrials.gov

Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

July 20, 2023

Conditions
Recurrent Early Pregnancy LossThyroid Diseases
Interventions
DRUG

Levothyroxine Pill

all participants will receive levothyroxine treatment of 1.6 micrograms per kg per day early in the morning on empty stomach.

Trial Locations (1)

10011

AL-Elwiyah Maternity Teaching Hospital, Baghdad

All Listed Sponsors
collaborator

Al-Elwyiah Maternity Teaching Hospital

UNKNOWN

lead

Al-Kindy College of Medicine

OTHER